SureTrader Stock Hero Advertisement SPDR Advertisement
Home > Boards > US OTC > Medical - Healthcare >

BioCorRx (BICX)

Add BICX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator Pip611, itsdetatti
Search This Board:
Last Post: 3/4/2015 12:42:19 PM - Followers: 91 - Board type: Free - Posts Today: 3



About BioCorRx

Program Overview

BioCorRx (OTCBB: BICX) is an alcohol treatment and rehabilitation company on the leading edge of alcohol addiction treatment. The company has developed a treatment program that is used by various licensed alcohol addiction clinics throughout the United States.

The program consists of two components:BioCorRx has the worldwide rights (except in Australia and New Zealand) to a highly effective, proprietary implant formulation of the FDA-approved drug, naltrexone. After being surgically implanted by a medical professional, the naltrexone implant significantly reduces cravings for alcohol for as long as a year in some patients, depending on individual metabolism rates.BioCorRx also owns a life coaching program that is tailored specifically to alcoholics. Once a patient has received the implant, they are encouraged to enter the life coaching program to maximize results.

BioCorRx’s revolutionary alcohol treatment program has an 85% success rate as reported by patients in routine telephone and face to face interviews. The implant is administered as an outpatient procedure, and in most cases, patients do not need to miss more than one day of work. They are then able to enter the private life coaching program without co-workers or family members knowing, unless they so choose.


Naltrexone is a medication that blocks the effects of drugs known as opioids and was approved by the FDA in 1995 for the treatment of alcohol dependence.

Learn more about the side effects of naltrexone.

Naltrexone blocks the parts of the brain that "feel pleasure” when patients use alcohol. When these areas of the brain are blocked, patients feel significantly less cravings for alcohol and even if alcohol is used, the effects of it will be extremely limited - making sobriety the only option. Once medical intervention has reduced the physical need for alcohol, the program goes on to address the patient's psychological needs. The combination of these treatments has resulted in the highest chance of sobriety.

naltrexone implant

While other companies use naltrexone in their treatments, the drug is typically administered in oral or injection form, requiring their patients to be responsible for taking the medication or scheduling an appointment.

While some patients do well with the oral formulation, there is a drawback that it must be taken daily and a patient whose craving becomes overwhelming can obtain the euphoria simply by skipping a dose before resuming abuse. Patients who received the program developed by BioCorRx are treated with a slow release dose that can last up to year in many patients (depending on various factors such as metabolism rates), which gives the patients a higher success rate for the treatment of alcoholism.

The outpatient naltrexone implant procedure can take as little as 20 minutes under local anesthetic in some cases. Most patients can return to work or their daily routine in the same day, without the cravings for alcohol.

Mission, Vision, Values


BioCorRx is focused on providing leadership and innovation for the treatment of alcoholism by offering a high-quality, comprehensive and cost-effective recovery program that allows patients and their loved ones to celebrate freedom from the cycle of alcohol addiction. Our program is built on a strong foundation of experience and practice, allowing for an improved quality of life for recovering alcoholics.


BioCorRx strives to be the preeminent, long-term alcohol recovery program used by treatment centers around the world for alcoholics, as well as their family and friends. By providing patients a "Fresh Start" on life, they have the opportunity to live happier, healthier, more productive lives away from the damaging impact of alcohol. We have built an organization that is committed to nurturing research for cutting-edge alcohol recovery technologies and integrating those technologies with comprehensive alcohol recovery treatment programs.


BioCorRx provides the opportunity and tools to treatment centers so they can help patients live happier, healthier, and more productive lives to those suffering from alcohol addiction (as well as their family and friends) by helping them break the addiction cycle and live alcohol-free. We want patients to celebrate freedom from the past and hope for the future. Our team consists of physicians, coaches, founders and management that are committed to providing high-quality services and adherence to ethical care.

Our goal is to give our treatment center partners the ability to deliver our program in a timely, warm and compassionate way to give patients, as well as their families and friends, peace of mind. To achieve this, BioCorRx has built its program around highly-qualified alcohol addiction specialists and effective treatment solutions.

We are committed to quality and continuous improvement in order to meet our partners’ needs for an individualized program dedicated to alcohol addiction recovery.

Investors Overview

BioCorRx is uniquely poised to gain significant market share of the $22 billion annual alcohol treatment market in the US.

More than 7% of the US population ages 18 years and older or 13.8 million Americans have problems with drinking, including 8.1 million people who suffer from alcoholism. And the costs financially are staggering. Alcohol dependency and abuse costs the US over $220 billion a year. For the sake of comparison, this is greater than the amount of money spent to combat cancer ($196 billion) and obesity ($133 billion).

BioCorRx intends to distribute the program to a new clinic in the United States every 60 to 90 days. Clinics using our program are also holding discussions with major health insurance providers to pay for all or a portion of the treatment fees.

Business Model

BioCorRx’s research has discovered that demand for its services are high and that growth in highly marketed segments of the population may be achieved through partnering with additional clinic sites. The company is also exploring the sub-licensing of the program to select regions of the US and internationally.

BioCorRx's goal is to meet its growth targets through licensing opportunities by promoting its naltrexone implant product and counseling service model to existing medical clinics and treatment centers that will purchase the program and/or product from the company. In addition, Fresh Start Private intends to open corporately owned clinics in select key markets where it is deemed appropriate.

Stock Price & Charts

BioCorRx is a fully reporting company. Financial reports and other reports are available for view or by visiting the online website. Audited financial reports are available quarterly.

Company Structure Details

  • Legal name: BioCorRx
  • Sector: Healthcare
  • Industry: Specialized Health Services
  • Full Time Employees: 4
  • Public Company: SEC Reporting and fully audited
  • Symbol: BICX
  • Exchange: OTCBB
  • Outstanding: 117,800,000
  • Authorized: 200,000,000
  • CUSIP: 35804J102
  • NAICS Code: 623220
  • SIC Number: 8093
  • Transfer Agent: Columbia Stock Transfer Company, 1869 E. Seltice Way #292, Post Falls, ID 83854 Tel (208) 664-3544
  • CIK: 0001443863
  • EIN: 26-1972677
  • Year End: December 31
  • State of incorporation: Nevada
  • Products: Alcohol rehabilitation, exclusive naltrexone implant technology
  • Address: 601 North Parkcenter Drive, Suite 103, Santa Ana, CA 92705 USA
  • Investors: 858-381-4677
  • Email:
  • Website:


CEYY Chart

Key Executives

Kent Emry - CEO, Director
Brady Granier -COO, Director
Lourdes Felix -CFO, Director
Dr. Jorge Andrade, Jr. - Director
Neil Muller -Co-Founder and President, Director 

Locations of independently owned clinics using our Fresh Start Program

Start Fresh Recovery
720 N. Tustin Ave.
Suite 206
Santa Ana, CA 92705

Start Fresh Executive Recovery
367 E Virginia Ave
Phoenix, AZ 85004
855-393-HOPE (4673) 

Fresh Start Private Florida
1415 Panther Lane
Suites 313-320
Naples, FL 34109

Start Fresh Alcohol Recovery Center
2827 S. 88th St
Omaha NE 68124

Coming Soon!

• San Francisco, California
• Chandler, Arizona
• North Scottsdale, Arizona
• Connecticut

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#4268  Sticky Note SmallCapVoice Interview with Brady Granier(COO)and Jeremy Miller Interview Pip611 10/26/13 06:31:25 PM
#6670   Selling !!! Only 4500 shares :) DREAM BIG 03/04/15 12:42:19 PM
#6669   Someone selling again today... Let's get this train inet 03/04/15 11:34:11 AM
#6668   Nice to see the .10 up on the DREAM BIG 03/04/15 08:31:42 AM
#6667   .08 got hit . DREAM BIG 03/03/15 03:41:15 PM
#6666   0.089 on the ASK ............. GOOOOOOOOOOOOO BICX :) DREAM BIG 03/03/15 02:45:35 PM
#6665   This is going to be epic someday - SrwDiesel 03/03/15 10:13:45 AM
#6664 DREAM BIG 03/03/15 08:49:20 AM
#6663   Something is up ;)) DREAM BIG 03/02/15 09:08:56 PM
#6662   Clay trader in the house! Pip611 03/02/15 05:00:21 PM
#6661   * * $BICX Video Chart 03-02-15 * * ClayTrader 03/02/15 04:32:14 PM
#6660   2014 was a pivotal year for BioCorRx, Inc. SrwDiesel 03/02/15 02:36:30 PM
#6659   Well yippee kai yea, looks like a bit Fido 03/02/15 11:47:27 AM
#6658   10Q Due in 10 business days ( Counting DREAM BIG 03/02/15 09:36:30 AM
#6657   In Case you missed it :))) DREAM BIG 03/02/15 09:35:31 AM
#6656   The thing I hope to hear soon has jugs 02/28/15 04:42:04 PM
#6655   So are The Bosley Boys still in the inet 02/28/15 12:23:59 PM
#6654   POWWWWWWWWWWWWWWWER HOUR !! DREAM BIG 02/27/15 02:56:45 PM
#6653   Clip from today's PR: Pip611 02/27/15 11:10:41 AM
#6652   I don't think the new places will be itsdetatti 02/27/15 11:01:19 AM
#6651   I'm all for positive news...but if people are stenz902 02/27/15 09:40:49 AM
#6650   Today's News + 10Q (Due in 2 weeks) DREAM BIG 02/27/15 09:32:22 AM
#6649   Los Angeles , Feb. 27, 2015 DLP 02/27/15 09:09:53 AM
#6648   BiocorRx Potential Medical Services Provider "Physicians Business S DREAM BIG 02/27/15 08:17:22 AM
#6647   BiocorRx New Marketing Partner "Myriad Medical Marketing" DREAM BIG 02/27/15 08:14:12 AM
#6646   NEWS ! DREAM BIG 02/27/15 08:10:43 AM
#6645   8K ;)) Current Report Filing (8-k) Source: Edgar (US DREAM BIG 02/26/15 03:42:28 PM
#6644   More clinics opening = more revenue = PPS Busey 02/26/15 10:07:04 AM
#6643   Agree!! There are enough clinics either controlled Fido 02/25/15 08:42:10 PM
#6642   I don't think anymore clinic openings will impact Pip611 02/25/15 05:30:07 PM
#6641   Agree. JA's selling will one day end Fido 02/25/15 12:10:37 PM
#6640   Not worried at all !! DREAM BIG 02/25/15 12:07:34 PM
#6639   here we gooooooo !! 0.75 on the ask DREAM BIG 02/25/15 10:45:58 AM
#6638   With a bankruptcy, he may have no choice Fido 02/25/15 10:40:06 AM
#6637   Always a pleasure dream. Let's hope JA sees Pip611 02/25/15 08:02:52 AM
#6636   Hear ;)) DREAM BIG 02/25/15 08:01:03 AM
#6635   Always nice to here from you pipe611 ..;) DREAM BIG 02/25/15 07:04:23 AM
#6634   Lets hope the selling is over for now. Pip611 02/25/15 06:48:01 AM
#6633   After all of today's drama we actually closed DREAM BIG 02/24/15 04:06:30 PM
#6632   100% agree ..... Out of the 600k+ traded DREAM BIG 02/24/15 03:56:27 PM
#6631   No bad news that we know of to nickyd 02/24/15 02:48:00 PM
#6630   yeah it sucks... the investors need something here... SrwDiesel 02/24/15 02:13:29 PM
#6629   I Can't believe that AJ is that desperate DREAM BIG 02/24/15 01:39:10 PM
#6628   According to his filing he intended to sell autobob 02/24/15 01:28:57 PM
#6627   PPS will rebound with the next clinic opening, Busey 02/24/15 12:10:40 PM
#6626   No concern here. The company is still opening Busey 02/24/15 12:05:56 PM
#6625   No concern here. The company is still opening Busey 02/24/15 12:05:56 PM
#6624   About 10.2M shares left...I think the had 10.42 itsdetatti 02/24/15 11:58:34 AM
#6623   Selling and more selling. Two year low is willlbone 02/24/15 11:30:57 AM
#6622   He registered 800k shares 2 weeks ago , DREAM BIG 02/24/15 11:11:51 AM
#6621   Biocorrx (OTCMKTS:BICX) Director Jorge Andrade, Jr. sold 215,000 shares captainhook002 02/24/15 07:30:17 AM